How do I differentiate obesity‑hypoventilation syndrome from central sleep apnea in a morbidly obese adult with daytime somnolence, hypercapnia, and nocturnal breathing disturbances?

Differentiating Obesity Hypoventilation Syndrome from Central Sleep Apnea

In a morbidly obese adult with daytime somnolence, hypercapnia, and nocturnal breathing disturbances, the key differentiator is that obesity hypoventilation syndrome (OHS) requires documented daytime hypercapnia (PaCO₂ >45 mm Hg) with BMI >30 kg/m², while central sleep apnea (CSA) is characterized by >50% of respiratory events being central in nature without necessarily having daytime hypercapnia. 1

Diagnostic Approach

Step 1: Confirm Daytime Hypercapnia

• Measure arterial blood gases during wakefulness in patients with high clinical suspicion (severely obese with typical symptoms, daytime hypoxemia) 1
• If suspicion is lower (<20%), use serum bicarbonate as a screening tool:
  • Bicarbonate <27 mmol/L effectively excludes OHS (sensitivity 85.7%, specificity 89.5%, negative predictive value 95.9%) 1, 2
  • Bicarbonate ≥27 mmol/L warrants arterial blood gas measurement to confirm hypercapnia 1, 3

Step 2: Obtain Polysomnography

Polysomnography is mandatory to determine the pattern of sleep-disordered breathing and distinguish between conditions 1

Key polysomnographic findings:

For OHS:

• Approximately 90% have coexistent obstructive sleep apnea (AHI >5 events/h) 1
• 70% have severe OSA (AHI >30 events/h) 1
• 10% demonstrate pure sleep hypoventilation without significant obstructive events 4
• Sustained oxygen desaturation during sleep
• May show sustained flow limitation with desaturation 4

For CSA:

• >50% of respiratory events must be central (cessation of airflow with absent respiratory effort) 5
• Often presents with Cheyne-Stokes breathing pattern
• Posthyperventilation phenomenon is the typical mechanism 5
• Does not require daytime hypercapnia for diagnosis 5

Critical Distinguishing Features

Clinical Presentation Differences

OHS-specific features:

• Daytime hypercapnia is definitional (PaCO₂ >45 mm Hg at sea level) 1
• Elevated serum bicarbonate (compensatory metabolic alkalosis) 1, 2
• Daytime SaO₂ ≤95% has 64.4% sensitivity and 73.9% specificity for OHS 3
• More severe daytime sleepiness (Epworth score 14.0 vs 11.9 in obese OSA) 3
• Higher rates of hypertension (67.8% vs 53.2%) 3
• Reduced lung function (lower FVC% and FEV₁%) 3

CSA-specific features:

• May have normal daytime PaCO₂ or even hypocapnia 5
• Often associated with heart failure, opioid use, or high altitude 5
• Central respiratory drive abnormalities rather than mechanical/obesity-related restriction 5
• Increased chemosensitivity (except in opioid-associated CSA) 5

Common Pitfalls to Avoid

Pitfall 1: Assuming All Obese Patients with Sleep-Disordered Breathing Have OSA

• 12 of 23 patients (52%) with OHS demonstrated central sleep hypoventilation in addition to variable obstructive events 4
• Mixed patterns are common and require careful polysomnographic interpretation 4

Pitfall 2: Relying on Clinical Features Alone

• OHS encompasses diverse pathophysiologic disturbances that cannot be distinguished clinically at presentation 4
• Arterial blood gas measurement is essential when bicarbonate ≥27 mmol/L 1

Pitfall 3: Misclassifying Hypopneas

• Without esophageal pressure monitoring, the true nature (central vs obstructive) of hypopneas can be challenging to determine 5
• Many patients present with mixed disorders requiring treatment addressing both components 5

Pitfall 4: Overlooking Alternative Causes

• Must exclude other causes of hypoventilation (neuromuscular disease, chest wall disorders, severe COPD, hypothyroidism) before diagnosing OHS 1
• Opioid use can cause CSA with depressed respiratory drive, distinct from other CSA mechanisms 5

Treatment Implications of Correct Diagnosis

For OHS:

• Positive airway pressure therapy is indicated 1
• CPAP is first-line if severe OSA coexists (AHI >30) 1
• Noninvasive ventilation if predominantly hypoventilation or inadequate CPAP response 1
• Weight loss interventions (25-30% body weight loss for resolution) 1

For CSA:

• Treatment depends on underlying etiology (heart failure, opioids, etc.) 5
• May require different PAP modalities or adaptive servo-ventilation
• Addressing underlying conditions is paramount 5

Algorithmic Summary

1. Obese patient with daytime somnolence + nocturnal breathing disturbances
2. Check serum bicarbonate:
   • <27 mmol/L → OHS unlikely, consider other diagnoses
   • ≥27 mmol/L → Proceed to ABG
3. Arterial blood gas:
   • PaCO₂ >45 mm Hg → Suspect OHS
   • Normal PaCO₂ → Consider CSA or OSA alone
4. Polysomnography (mandatory):
   • Predominantly obstructive events + daytime hypercapnia → OHS with OSA
   • Predominantly central events (>50%) ± normal daytime PaCO₂ → CSA
   • Mixed pattern → Treat both components
5. Exclude alternative causes of hypoventilation

The presence of daytime hypercapnia in an obese patient with sleep-disordered breathing, after excluding other causes, definitively establishes OHS rather than isolated CSA. 1